Both drugs are a pancreatic enzyme that is prescribed for patients who do not have enough of the natural enzyme.

For diagnosis, measures of liver biochemistry and pancreatic enzymes are performed.

Tests that show the release of pancreatic enzymes include:

A 2004 study using pancreatic enzymes in a mouse model of pancreatic cancer showed positive results.

Some patients benefit from the use of pancreatic enzymes on a supplemental basis.

A lack of pancreatic digestive enzymes leaves patients unable to digest and absorb fat.

The pancreatic enzymes are thought to be the specific anticancer component of the Gonzalez program.

Published animal studies focus on the role of pancreatic enzymes in cancer treatment rather than the regimen as a whole.

Taking specific vitamin and mineral supplements plus pancreatic enzymes is the second component of the regimen.

The pancreatic enzyme is taken by mouth, in a capsule.